APPLIED THERAPEUTICS, INC.
Profile
Company Names
APPLIED THERAPEUTICS, INC.
APPLIED THERAPEUTICS INC.
Addresses
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY 10017
545 5TH AVENUE, SUITE 1400, NEW YORK, NY 10173
340 MADISON AVENUE, 19TH FLOOR, NEW YORK, NY 10173
Phone Numbers
212-220-9226
212-220-9319
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, OTHER HEALTH CARE
Year Incorporated:
2016
State Incorporated:
DELAWARE
Total Amount Raised:
$189,238,955.00
Number of Funding Rounds:
6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2024-02-27
$99,997,998.00
$99,997,998.00
$0.00
Equity
5
2023-04-23
$30,000,002.00
$30,000,002.00
$0.00
Equity
4
2019-11-07
$20,014,988.00
$20,014,988.00
$0.00
Equity
3
2018-11-05
$27,158,092.00
$56,584,093.00
$29,426,001.00
Equity
2
2018-02-08
$6,000,000.00
$6,000,000.00
$0.00
Debt
1
2017-01-26
$6,067,875.00
$7,000,000.00
$932,125.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
FRANKLIN
BERGER
DIRECTOR
FIVE PRIME THERAPEUTICS INC
| ITHERX PHARMA, INC.
| IMMUNE DESIGN CORP.
| ALZHEON, INC.
| ATRECA, INC.
| ESSA PHARMA INC.
| CERUS ENDOVASCULAR LTD
| KEZAR LIFE SCIENCES, INC.
| BELLUS HEALTH INC.
| APPLIED THERAPEUTICS INC.
| ATEA PHARMACEUTICALS, INC.
| RAIN THERAPEUTICS INC.
| WALKING FISH THERAPEUTICS, INC.
| SATELLOS BIOSCIENCE INC.
LES
FUNTLEYDER
DIRECTOR, EXECUTIVE OFFICER
JOEL
MARCUS
DIRECTOR
INTRA CELLULAR THERAPIES INC
| SANTA MARIA BIOTHERAPEUTICS, INC.
| PINTA BIOTHERAPEUTICS, INC.
| NINA BIOTHERAPEUTICS, INC.
| LODO THERAPEUTICS CORP
| PETRA PHARMA CORP
| YUMANITY HOLDINGS, LLC
| APOGEN BIOTECHNOLOGIES, INC.
| BORAGEN, INC.
| RODEO THERAPEUTICS CORP
| PRONIRAS CORP
| APPLIED THERAPEUTICS INC.
| VINDARA, INC.
| MAGNOLIA NEUROSCIENCES CORP
| FREQUENCY THERAPEUTICS, INC.
| EQUILIBRE BIOPHARMACEUTICALS CORP.
| ARE-WINTER STREET REIT, LLC
| ARE-MA REGION NO. 102 REIT, LLC
| ALTPEP CORP
| ARE-MA REGION NO. 107 REIT, LLC
| TREX HOLDINGS INC.
JOEL
S.
MARCUS
DIRECTOR
SHOSHANA
SHENDELMAN
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-02-27
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-04-23
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-11-07
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
